Nav: Home

Non-opioid drug relieves pain in mice, targets immune cells

July 05, 2018

Faced with the epidemic of opioid addiction, researchers have been charged with finding other strategies to treat pain. Their efforts largely have focused on nerve cells that transmit pain signals to the spinal cord and brain. But new research, led by scientists at Washington University School of Medicine in St. Louis, shows that targeting receptors on immune cells may be more effective, particularly for chronic pain.

Recently, a non-opioid, investigational drug called EMA401 has shown promise as a treatment for lingering nerve pain following shingles infection. While trying to understand how that drug helped control pain, the Washington University research team was surprised to find that it doesn't hit nerve cells; rather, it targets a receptor on immune cells.

Their findings are published July 2 in The Journal of Neuroscience.

"We are in dire need of good pain-killing drugs, particularly non-opioid drugs," said principal investigator D.P. Mohapatra, PhD, an associate professor in anesthesiology. "Generally, scientists have the understanding that targets for treating pain must be within the nervous system. It turns out that the target here is not on nerve cells, but on immune cells called macrophages."

The investigational drug inhibits the angiotensin II type 2 receptor that is targeted by medications that lower blood pressure. Angiotensin is a hormone that causes blood vessels to constrict, increasing blood pressure.

This drug was thought to work by interacting with the type 2 receptor on nerve cells -- the same cells that carry pain signals. But when Mohapatra and his colleagues at the Washington University Pain Center looked more closely, they found that theory was wrong.

"When we took nerve cells from mice, put them in a culture dish and added the angiotensin hormone, nothing happened," said co-investigator Andrew Shepherd, PhD, an instructor in anesthesiology. "There was no angiotensin type 2 receptor on sensory neurons, so pain signals couldn't be transmitted."

But in other experiments in which they injected the angiotensin hormone into mice, the animals indicated they felt pain and withdrew their paws when touched.

"We found that the receptor the drug affected wasn't on the nerve cells; it was on macrophages, the immune cells," Shepherd said. "When we added macrophages to the dish alongside the nerve cells, the angiotensin could 'talk' to the macrophages, and then the macrophages 'talked' to the nerve cells, which then transmitted pain signals."

When the researchers reduced the number of macrophages in mice, the animals didn't appear to feel pain in response to an angiotensin injection. But as the macrophages repopulated over the course of a few days, the response to pain returned. To support these observations in mice and the culture dish, the researchers also have found increased numbers of macrophages alongside degenerating nerve fibers in skin biopsies taken from the legs of patients who have diabetic neuropathy.

Increasing the number of potential targets for painkillers and including targets such as receptors on immune cells may make it possible to develop more effective painkilling drugs with fewer side effects, Mohapatra said.

"The beauty of this drug is that, unlike an opioid, it doesn't cross the blood-brain barrier, so right away you eliminate a number of potentially harmful side effects, including addiction and the potential for abuse," he said. "And by widening the scope of potential targets to macrophages, it may be possible to develop more effective therapies for chronic, neuropathic pain."
-end-
Shepherd AJ, et al. Angiotensin II triggers peripheral macrophage-to-sensory neuron redox crosstalk to elicit pain. The Journal of Neuroscience, July 2, 2018.

This work was supported the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of of Neurological Disorders and Stroke, the National Heart, Lung and Blood Institute and the National Cancer Institute of the National Institutes of Health (NIH). Grant numbers P30 DK056341, NS069898, CA1711927, HL125805, DK102520, U01 DK101039, NS072432, NS065926 and NS042595. Additional funding from the Washington University Pain Center, the Danish Diabetes Academy (supported by the Novo Nordisk Foundation, and from the University of Texas STARs (Science and Technology Acquisition and Retention) program.

Washington University School of Medicine's 1,300 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Washington University School of Medicine

Related Immune Cells Articles:

Identification of new populations of immune cells in the lungs
In an article published in Nature Communications, the Immunophysiology Laboratory of the GIGA Institute, headed by Prof.
A genomic barcode tracker for immune cells
A new research method to pinpoint the immune cells that recognise cancer could significantly change how we treat the disease.
Scientists reminded immune cells on what side they should be
International group of scientists in the joint study of the laboratory of the Wistar Institute, University of Pittsburgh and I.M.
Dead cells disrupt how immune cells respond to wounds and patrol for infection
Immune cells prioritise the clearance of dead cells overriding their normal migration to sites of injury.
Study gives new perspective on production of blood cells and immune cells
A new study provides a thorough accounting of blood cell production from hematopoietic stem cells.
Gut immune cells play by their own rules
Only a few vaccines -- for example, against polio and rotavirus -- can be given orally.
Revealed: How the 'Iron Man' of immune cells helps T cells fight infection
The immune system's killer T cells are crucial in fighting viral infections.
A bad influence: the interplay between tumor cells and immune cells
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment.
Immune cells help older muscles heal like new
The immune system's macrophage cells are critical to growing muscle tissues in a lab, say the biomedical engineers at Duke University who earlier reported the world's first self-healing lab-grown muscles.
How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.
More Immune Cells News and Immune Cells Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.